Search sector opportunities

EPSRC and Defra are hosting workshops in June 2025 to gather input on future circular economy research beyond recycling — including areas like repair, reuse, ecodesign and circular business models. Express your interest by 19 May 2025 to help shape strategic priorities and connect with peers across disciplines.

UK regulators can now apply for up to £1.6 million from the £5 million Engineering Biology Sandbox Fund Round 2 to run projects that drive pro-innovation regulatory reform in engineering biology.

£2.1 million is available to support UK bioscience researchers and businesses in accessing and benefiting from access to STFC skills, expertise, capabilities and world-class facilities.

The Golden Ticket programme is aimed at early-stage biotech companies focused on novel drug targets and transformational medicines, with robust research plans and potential for successful research development.

The Opportunities in STEM campaign in partnership with Mediaplanet will be launching on June 19 in the New Scientist magazine ahead of International Women in Engineering Day. 

Apply for UKRI’s Future Leaders Fellowships (Round 10) to secure funding for ambitious, independent research or innovation projects—open to early career researchers and innovators from eligible academic or non-academic institutions, with projects lasting up to four years and no cost limits.

Help shape the future of biopharma innovation by taking this 10-minute survey on biopharma entrepreneurship ecosystems and the support start-ups receive globally.

LifeArc's newly launched B-SMArT antibody discovery platform offers collaborators a clinically validated transgenic mouse model (Kymab/Sanofi) and advanced single B-cell selection technologies (Beacon and FACS) to generate fully human antibodies ready for in vivo testing.

This nationwide initiative is calling on companies, teams, and individuals to commit to a fitness challenge while raising vital funds for translational cancer research—helping life-saving innovations move from the lab to patients faster.